- Profile
- Personal Information
- Publications
Experts in General Science
Cheng-Li Liu Miguel Acevedo Faramarz Helali Peter Andreas In-Ju Kim Rabiul Ahasan Anil K. Tripathi Isamu Nishida Gregor Harih Stoica George Tal Amasay Brian Rothman Semra Peksoz Ashok Sharma Mahesh Kumar Vyas Arjunsingh Baghel Calatayud Paul Andre MARCO ADAMINA Heba Barazi AEBERSOLD URSULA View MoreDavid G. Kelly
Executive Vice President, Company Secretary and Ma
General Science
Horizon Pharma
Macedonia
David joined Horizon Pharma in September 2014 as executive vice president, managing director, Ireland and was appointed company secretary in November 2014. Prior to joining Horizon Pharma, he served as chief financial officer for Vidara Therapeutics, and was previously chief financial officer of AGI Therapeutics. He also served as senior vice president of Warner Chilcott (formerly Galen), a fully integrated specialty pharmaceutical company. While at Warner Chilcott, he led the company’s successful IPO on NASDAQ. In addition, David has held roles with Elan Corporation and KPMG. David joined Horizon Pharma in September 2014 as executive vice president, managing director, Ireland and was appointed company secretary in November 2014. Prior to joining Horizon Pharma, he served as chief financial officer for Vidara Therapeutics, and was previously chief financial officer of AGI Therapeutics. He also served as senior vice president of Warner Chilcott (formerly Galen), a fully integrated specialty pharmaceutical company. While at Warner Chilcott, he led the company’s successful IPO on NASDAQ. In addition, David has held roles with Elan Corporation and KPMG.
General Science